PHH NASDAQ
Park Ha Biological Technology Co., Ltd.
1W: -6.5%
1M: -34.4%
3M: -52.6%
$0.39
Last traded 2025-11-24 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$2M
-3.1% ▼
5Y CAGR: -67.1%
Gross Profit
$2M
+1.8% ▲
5Y CAGR: -67.7%
Operating Income
$794K
-32.8% ▼
Net Income
$479K
-43.8% ▼
EPS (Diluted)
$0.02
-43.7% ▼
EBITDA
$816K
-32.0% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2017 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $456M | $931K | $2M | $2M | $2M |
| YoY Growth | -26.7% | +0.0% | +106.2% | +28.1% | -3.1% |
| Cost of Revenue | $0 | $311K | $509K | $311K | $195K |
| Gross Profit | $456M | $620K | $1M | $2M | $2M |
| Gross Margin | 100.0% | 66.6% | 73.5% | 87.4% | 91.8% |
| R&D Expenses | $0 | $0 | $61K | $31K | $37K |
| SG&A Expenses | $338M | $1M | $1M | $785K | $1M |
| Operating Expenses | -$752M | $1M | $1M | $968K | $1M |
| Operating Income | -$296M | -$501K | $197K | $1M | $794K |
| Operating Margin | -64.9% | -53.8% | 10.3% | 48.0% | 33.3% |
| Interest Expense | $73M | $1K | $194 | $0 | $0 |
| Income Before Tax | -$273M | -$485K | $190K | $1M | $793K |
| Tax Expense | -$79M | $0 | -$1K | $330K | $315K |
| Net Income | -$194M | -$485K | $191K | $852K | $479K |
| Net Margin | -42.5% | -52.1% | 10.0% | 34.6% | 20.1% |
| EPS (Diluted) | $-4.14 | $-0.02 | $0.01 | $0.03 | $0.02 |
| EBITDA | -$282M | -$445K | $221K | $1M | $816K |
| Shares Outstanding | 47M | 26M | 26M | 26M | 26M |